Synonyms:396129-53-6, LY-364947, LY364947, 4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE, 4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline, TGF-beta RI Kinase Inhibitor, LY 364947, HTS 466284, 4-(5-pyridin-2-yl-1H-pyrazol-4-yl)quinoline, HTS-466284, HTS466284, 4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline, CHEMBL261454, 4-(3-pyridin-2-yl)(1h)-pyrazol-4-yl quinoline, 4-[5-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline, MFCD00800758, 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline, 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline, TbetaR-I Inhibitor, SR-01000385325, Quinoline, 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-, 1py5, Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor, Peakdale1_000394, SCHEMBL373665, GTPL6050, Isoxazol-5-ylmethyl-methylamine, SCHEMBL21233972, BDBM21492, CHEBI:91198, CHEBI:92118, HMS519B20, AOB6754, DTXSID90332266, EX-A133, HMS2043N21, HMS3229M09, HMS3269P09, HMS3648O10, HMS3677D10, HMS3742E17, BCP05350, WQA12953, s2805, ZINC15894680, AKOS015854224, AKOS025394671, AKOS026750326, BCP9000886, CCG-206795, CS-3451, DB03921, PS-7269, SB19489, NCGC00167839-01, NCGC00167839-15, AC-30262, HY-13462, PY1, FT-0676988, X5937, EC-000.2417, 4-(3-pyridin-2-yl)-1h-pyrazol-4-ylquinoline, A13446, LY-364947, >=98% (HPLC), A873615, [3-(pyridin-2-yl)-4-(4-quinolinyl)]-1h-pyrazole, 4-[(3-Pyridin-2-yl)-1H-pyrazol-4-yl)]quinoline, J-513403, SR-01000385325-1, SR-01000385325-2, 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]??-quinoline, BRD-K06234293-001-01-8, Q27088977, LY-364947;4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]-quinoline;[3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole
Id:447966
Description:nan